Opinion|Articles|July 4, 2025
Top 10 Urology Times videos from the first half of 2025
Author(s)Urology Times staff
Fact checked by: Benjamin P. Saylor, Strategic Content Lead
Catch up on exclusive videos you may have missed from the first half of the year.
Advertisement
Advertisement
The first half of 2025 generated plenty of headlines in the urology space, ranging from conferences such as the 2025 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, American Urological Association 2025 Annual Meeting, and ASCO Annual Meeting. Besides conferences, other key headlines involved the FDA’s approval of perioperative durvalumab (Imfinzi) with neoadjuvant chemotherapy for adult patients with
Advertisement
Advertisement